Alira Health

Alira Health

Burden of Disease in COPD and Asthma Stratified by Eosinophils Levels

Asthma is a chronic lung disease affecting people of all ages, it is caused by inflammation and muscle tightening around the airways, which makes it harder to breathe. Chronic obstructive pulmonary disease (COPD) is a common lung disease which produces a restricted airflow; smoking and air pollution are the most common causes for this disease.

Evidence suggests that blood eosinophil levels (EOS) can influence the response to therapy in both asthma and COPD and predict future exacerbation outcomes.

Given this information, our Real-World Evidence (RWE) experts conducted two independent studies to characterize asthma and COPD burden stratified by EOS levels. Data was extracted from the UK Biobank, a large-scale biomedical database containing health information from half a million UK participants.

Our team presented the results of these studies through two posters during the ERS International Congress. View the posters below and discover the impact of raised EOS in asthma and COPD burden.

Published on:
October 4, 2023
Click below to download the full-screen versions.

Download: Burden of disease in Asthma stratified by eosinophils levels: a UK biobank study

burden of disease asthma and eosinophils


Download: Burden of disease in COPD stratified by eosinophils levels: a UK biobank study

burden of disease copd and eosinophils leveles



Learn more about our Real-World Solutions to leverage and interpret data across the entire healthcare ecosystem.

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.